Your browser doesn't support javascript.
Household Transmission of Influenza A Viruses in 2021-2022.
Rolfes, Melissa A; Talbot, H Keipp; McLean, Huong Q; Stockwell, Melissa S; Ellingson, Katherine D; Lutrick, Karen; Bowman, Natalie M; Bendall, Emily E; Bullock, Ayla; Chappell, James D; Deyoe, Jessica E; Gilbert, Julie; Halasa, Natasha B; Hart, Kimberly E; Johnson, Sheroi; Kim, Ahra; Lauring, Adam S; Lin, Jessica T; Lindsell, Christopher J; McLaren, Son H; Meece, Jennifer K; Mellis, Alexandra M; Moreno Zivanovich, Miriana; Ogokeh, Constance E; Rodriguez, Michelle; Sano, Ellen; Silverio Francisco, Raul A; Schmitz, Jonathan E; Vargas, Celibell Y; Yang, Amy; Zhu, Yuwei; Belongia, Edward A; Reed, Carrie; Grijalva, Carlos G.
  • Rolfes MA; Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Talbot HK; Vanderbilt University Medical Center, Nashville, Tennessee.
  • McLean HQ; Marshfield Clinic Research Institute, Marshfield, Wisconsin.
  • Stockwell MS; Columbia University, New York City, New York.
  • Ellingson KD; University of Arizona, Tucson.
  • Lutrick K; University of Arizona, Tucson.
  • Bowman NM; University of North Carolina at Chapel Hill.
  • Bendall EE; University of Michigan, Ann Arbor.
  • Bullock A; University of North Carolina at Chapel Hill.
  • Chappell JD; Vanderbilt University Medical Center, Nashville, Tennessee.
  • Deyoe JE; Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Gilbert J; University of Michigan, Ann Arbor.
  • Halasa NB; Vanderbilt University Medical Center, Nashville, Tennessee.
  • Hart KE; Vanderbilt University Medical Center, Nashville, Tennessee.
  • Johnson S; Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Kim A; Vanderbilt University Medical Center, Nashville, Tennessee.
  • Lauring AS; University of Michigan, Ann Arbor.
  • Lin JT; University of North Carolina at Chapel Hill.
  • Lindsell CJ; Vanderbilt University Medical Center, Nashville, Tennessee.
  • McLaren SH; Columbia University, New York City, New York.
  • Meece JK; Marshfield Clinic Research Institute, Marshfield, Wisconsin.
  • Mellis AM; Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Moreno Zivanovich M; University of North Carolina at Chapel Hill.
  • Ogokeh CE; Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Rodriguez M; Columbia University, New York City, New York.
  • Sano E; Columbia University, New York City, New York.
  • Silverio Francisco RA; Columbia University, New York City, New York.
  • Schmitz JE; Vanderbilt University Medical Center, Nashville, Tennessee.
  • Vargas CY; Columbia University, New York City, New York.
  • Yang A; University of North Carolina at Chapel Hill.
  • Zhu Y; Vanderbilt University Medical Center, Nashville, Tennessee.
  • Belongia EA; Marshfield Clinic Research Institute, Marshfield, Wisconsin.
  • Reed C; Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Grijalva CG; Vanderbilt University Medical Center, Nashville, Tennessee.
JAMA ; 329(6): 482-489, 2023 02 14.
Article in English | MEDLINE | ID: covidwho-2310661
ABSTRACT
Importance Influenza virus infections declined globally during the COVID-19 pandemic. Loss of natural immunity from lower rates of influenza infection and documented antigenic changes in circulating viruses may have resulted in increased susceptibility to influenza virus infection during the 2021-2022 influenza season.

Objective:

To compare the risk of influenza virus infection among household contacts of patients with influenza during the 2021-2022 influenza season with risk of influenza virus infection among household contacts during influenza seasons before the COVID-19 pandemic in the US. Design, Setting, and

Participants:

This prospective study of influenza transmission enrolled households in 2 states before the COVID-19 pandemic (2017-2020) and in 4 US states during the 2021-2022 influenza season. Primary cases were individuals with the earliest laboratory-confirmed influenza A(H3N2) virus infection in a household. Household contacts were people living with the primary cases who self-collected nasal swabs daily for influenza molecular testing and completed symptom diaries daily for 5 to 10 days after enrollment. Exposures Household contacts living with a primary case. Main Outcomes and

Measures:

Relative risk of laboratory-confirmed influenza A(H3N2) virus infection in household contacts during the 2021-2022 season compared with prepandemic seasons. Risk estimates were adjusted for age, vaccination status, frequency of interaction with the primary case, and household density. Subgroup analyses by age, vaccination status, and frequency of interaction with the primary case were also conducted.

Results:

During the prepandemic seasons, 152 primary cases (median age, 13 years; 3.9% Black; 52.0% female) and 353 household contacts (median age, 33 years; 2.8% Black; 54.1% female) were included and during the 2021-2022 influenza season, 84 primary cases (median age, 10 years; 13.1% Black; 52.4% female) and 186 household contacts (median age, 28.5 years; 14.0% Black; 63.4% female) were included in the analysis. During the prepandemic influenza seasons, 20.1% (71/353) of household contacts were infected with influenza A(H3N2) viruses compared with 50.0% (93/186) of household contacts in 2021-2022. The adjusted relative risk of A(H3N2) virus infection in 2021-2022 was 2.31 (95% CI, 1.86-2.86) compared with prepandemic seasons. Conclusions and Relevance Among cohorts in 5 US states, there was a significantly increased risk of household transmission of influenza A(H3N2) in 2021-2022 compared with prepandemic seasons. Additional research is needed to understand reasons for this association.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Influenza Vaccines / Influenza, Human / Influenza A Virus, H3N2 Subtype / COVID-19 Type of study: Cohort study / Diagnostic study / Observational study / Prognostic study Topics: Vaccines Limits: Adolescent / Adult / Child / Female / Humans / Male Country/Region as subject: North America Language: English Journal: JAMA Year: 2023 Document Type: Article Affiliation country: Jama.2023.0064

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Influenza Vaccines / Influenza, Human / Influenza A Virus, H3N2 Subtype / COVID-19 Type of study: Cohort study / Diagnostic study / Observational study / Prognostic study Topics: Vaccines Limits: Adolescent / Adult / Child / Female / Humans / Male Country/Region as subject: North America Language: English Journal: JAMA Year: 2023 Document Type: Article Affiliation country: Jama.2023.0064